← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2004First marketed drug
Dec 16, 2020First NDA
Dec 16, 2020Last known activity
Apr 30, 2026
Timeline
2000s
- Jun 1, 2000
MacroGenics— Founded
- Jul 17, 2008
Raven Biotechnologies— Acquired
2020s
- Dec 16, 2020
margetuximab— Marketing Organization
- Dec 16, 2020
margetuximab— NDA Organization
- Dec 16, 2020
margetuximab— NDA Secondary Org
Drugs by trial phase (39 distinct, 53 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Desmoplastic Small Round Cell Tumor
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Encephalitis
- Fever
- Head and Neck Neoplasms
- Hematologic Neoplasms
- Infections
- Lung Neoplasms
- Melanoma
- Meningitis
- Mesothelioma
- Neoplasm Metastasis
- Neoplasms
- Neuroblastoma
- Osteosarcoma
- Pancreatic Neoplasms
- Paralysis
- Prostatic Neoplasms
- Psoriasis
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Ewing
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
- Virus Diseases
- West Nile Fever
- Wilms Tumor
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT03133988Lead sponsorN/A—
- NCT04678466Lead sponsorN/A—
- NCT04678466Study directorN/A—
- NCT07223567CollaboratorPhase 2Apr 30, 2026
- NCT07071961CollaboratorPhase 2Jan 1, 2026
- NCT06730347OfficialPhase 2May 31, 2025
- NCT06730347Lead sponsorPhase 2May 31, 2025
- NCT06723236Lead sponsorPhase 1Mar 31, 2025
- NCT06723236OfficialPhase 1Mar 31, 2025
- NCT06227546CollaboratorPhase 2Apr 15, 2024
- NCT06242470Lead sponsorPhase 1Mar 6, 2024
- NCT06242470OfficialPhase 1Mar 6, 2024
- NCT06014255CollaboratorPhase 2Jan 1, 2024
- NCT05848011Lead sponsorPhase 2Sep 28, 2023
- NCT05848011Study directorPhase 2Sep 28, 2023
Details
- Founded
- Rockville, MD, US Jun 1, 2000
- First NDA
- Dec 16, 2020
- Last known activity
- Apr 30, 2026
Designations held
- Fast track